Sun Pharmaceutical Industries Ltd. closed 14.19% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.34% to 1,667.15 Indian rupees Wednesday, on what proved to ...

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...

Sun Pharmaceutical Industries has reached a settlement with Incyte Corporation regarding the Leqselvi drug, used for severe ...

Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is quoting at Rs 1725.7, up 2.56% on the ...

LEQSELVI has shown rapid results in clinical trials, with one-third of patients regaining nearly full scalp hair by Week 24.

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

Sun Pharma settles litigation with Incyte over Leqselvi, launches product for severe alopecia areata treatment in the US.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts.

We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In ...

Calling upon all relevant stakeholders to position local pharmaceutical manufacturing as a ‘thrust industry’ which can reduce ...

Morgan Stanley sees earnings growth in the pharma sector moderating in FY25–27, though robust balance sheets could support ...